This strain contains 20 protein-level mutations:
We identified all possible linear viral peptides affected by these mutations. Whenever it was possible, we matched the reference peptide with the mutated one. For example, D -> L mutation transformed SDNGPQNQR to SLNGPQNQR. Cases when it was not meaningful included deletions and insertions at the flanks of the peptide, e.g., HV deletion in NVTWFHAIHV peptide.
Then, we predicted binding affinities between the selected peptides and frequent HLA alleles. Predictions were made with NetMHCpan-4.1 and NetMHCIIpan-4.0. The binding affinities were classifies into three groups:
Here we report HLA-peptide interactions whose affinity was altered by at least two folds. Note that mutations with empty set of altered interactions are not showed.
Weaker binding was found for 33 epitopes, while stronger binding was found for 31 entries. There are 672 tight binders for the HLA-A*02:02 in the reference immunopeptidome (IC50 affinity ≤ 50 nM); 9 of them became non-tight binders (1.3%) and 8 novel tight binders appeared (1.2%). To avoid possible divisions by zero, we used + 1 regularization term in denominators when calculating percentages.
Reference VFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYF
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated VFRSSVLHSTRDLFLPFFSNVTWFHVI‑‑SGTNGTKRFDNPVLPFNDGVYF
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*02:02 | VTWFHAIHV | VTWFHVI | 369 | - |
HLA-A*02:02 | NVTWFHAIHV | NVTWFHVI | 468 | 14619 |
HLA-A*02:02 | FSNVTWFHA | FSNVTWFHV | 741 | 115 |
HLA-A*02:02 | FFSNVTWFHA | FFSNVTWFHV | 328 | 79 |
HLA-A*02:02 | FLPFFSNVTWFHA | FLPFFSNVTWFHV | 117 | 32 |
HLA-A*02:02 | FLPFFSNVTWFHAI | FLPFFSNVTWFHVI | 151 | 392 |
Reference RSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFAST
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated RSSVLHSTRDLFLPFFSNVTWFHVI‑‑SGTNGTKRFDNPVLPFNDGVYFAST
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*02:02 | VTWFHAIHV | VTWFHVI | 369 | - |
HLA-A*02:02 | NVTWFHAIHV | NVTWFHVI | 468 | 14619 |
Reference PCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTG
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated PCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTG
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*02:02 | DVNCTEVPV | GVNCTEVPV | 4099 | 213 |
HLA-A*02:02 | QVAVLYQDV | QVAVLYQGV | 1107 | 188 |
HLA-A*02:02 | NQVAVLYQDV | NQVAVLYQGV | 269 | 116 |
Reference PLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQ
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated PLLTDEMIAQYTSALLAGTITSGWTLGAGAALQIPFAMQMAYRFNGIGVTQ
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*02:02 | LLAGTITSGWTF | LLAGTITSGWTL | 2639 | 26 |
HLA-A*02:02 | ALLAGTITSGWTF | ALLAGTITSGWTL | 7387 | 110 |
HLA-A*02:02 | TFGAGAALQI | TLGAGAALQI | 7571 | 192 |
HLA-A*02:02 | LLAGTITSGWTFG | LLAGTITSGWTLG | 3915 | 444 |
HLA-A*02:02 | ITSGWTFGA | ITSGWTLGA | 257 | 1444 |
HLA-A*02:02 | WTFGAGAAL | WTLGAGAAL | 146 | 473 |
Reference LWPVTLACFVLAAVYRINWITGGIAIAMACLVGLMWLSYFIASFRLFARTR
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated LWPVTLACFVLAAVYRINWITGGIATAMACLVGLMWLSYFIASFRLFARTR
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*02:02 | WITGGIAIA | WITGGIATA | 333 | 88 |
HLA-A*02:02 | AIAMACLVGL | ATAMACLVGL | 41 | 133 |
HLA-A*02:02 | GIAIAMACL | GIATAMACL | 110 | 50 |
HLA-A*02:02 | GIAIAMACLV | GIATAMACLV | 84 | 39 |
HLA-A*02:02 | GGIAIAMACL | GGIATAMACL | 596 | 288 |
Reference MYSFVSEETGTLIVNSVLLFLAFVVFLLVTLAILTALRLCAYCCNI
|||||||||||||||||||| |||||||||||||||||||||||||
Mutated MYSFVSEETGTLIVNSVLLFFAFVVFLLVTLAILTALRLCAYCCNI
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*02:02 | FLAFVVFL | FFAFVVFL | 24 | 3923 |
HLA-A*02:02 | IVNSVLLFL | IVNSVLLFF | 25 | 3332 |
HLA-A*02:02 | LIVNSVLLFL | LIVNSVLLFF | 70 | 5517 |
HLA-A*02:02 | LFLAFVVFLL | LFFAFVVFLL | 16 | 1201 |
HLA-A*02:02 | FLAFVVFLLVTL | FFAFVVFLLVTL | 36 | 2659 |
HLA-A*02:02 | FLAFVVFLLV | FFAFVVFLLV | 12 | 792 |
HLA-A*02:02 | FLAFVVFLLVTLAI | FFAFVVFLLVTLAI | 185 | 10954 |
HLA-A*02:02 | TLIVNSVLLFL | TLIVNSVLLFF | 147 | 7129 |
HLA-A*02:02 | FLAFVVFLL | FFAFVVFLL | 3 | 125 |
HLA-A*02:02 | FLAFVVFLLVT | FFAFVVFLLVT | 334 | 13428 |
HLA-A*02:02 | FLAFVVFLLVTLA | FFAFVVFLLVTLA | 101 | 3916 |
HLA-A*02:02 | LFLAFVVFLLV | LFFAFVVFLLV | 427 | 7784 |
HLA-A*02:02 | LFLAFVVFLLVTL | LFFAFVVFLLVTL | 399 | 6794 |
HLA-A*02:02 | SVLLFLAFVVFLL | SVLLFFAFVVFLL | 157 | 1091 |
HLA-A*02:02 | LAFVVFLLV | FAFVVFLLV | 1446 | 408 |
HLA-A*02:02 | VLLFLAFVVFL | VLLFFAFVVFL | 934 | 457 |
Reference MFHLVDFQVTIAEILLIIMRTFKVSIW
| |||||||||||||||||||||||||
Mutated M‑HLVDFQVTIAEILLIIMRTFKVSIW
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*02:02 | FHLVDFQVTI | - | 9 | - |
HLA-A*02:02 | FHLVDFQVTIA | - | 411 | - |
HLA-A*02:02 | MFHLVDFQV | MHLVDFQV | 403 | 3464 |
HLA-A*02:02 | MFHLVDFQVTI | MHLVDFQVTI | 51 | 11 |
Reference VKPLLVPHHVVATVQEIQLQAAVGELLLLEWLAMAVMLLLLCCCLTD
||||||||||||||||||||||||| |||||||||||||||||||||
Mutated VKPLLVPHHVVATVQEIQLQAAVGEFLLLEWLAMAVMLLLLCCCLTD
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*02:02 | QLQAAVGEL | QLQAAVGEF | 92 | 2789 |
HLA-A*02:02 | IQLQAAVGEL | IQLQAAVGEF | 170 | 4413 |
HLA-A*02:02 | LLLLEWLAM | FLLLEWLAM | 1379 | 150 |
HLA-A*02:02 | LLLLEWLA | FLLLEWLA | 2866 | 389 |
HLA-A*02:02 | LLLLEWLAMA | FLLLEWLAMA | 67 | 13 |
HLA-A*02:02 | LLLLEWLAMAVMLL | FLLLEWLAMAVMLL | 714 | 164 |
HLA-A*02:02 | LLLLEWLAMAV | FLLLEWLAMAV | 453 | 147 |
HLA-A*02:02 | QLQAAVGELLL | QLQAAVGEFLL | 530 | 186 |
HLA-A*02:02 | LQAAVGELLL | LQAAVGEFLL | 100 | 42 |
Reference FNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVYD
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated FNMVYMPASWVMRIMTWLDMVDTSL‑‑‑KLKDCVMYASAVVLLILMTARTVYD
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*02:02 | FKLKDCVMYA | - | 8 | - |
HLA-A*02:02 | SGFKLKDCVMYA | - | 126 | - |
HLA-A*02:02 | MTWLDMVDTSLSGFKL | MTWLDMVDTSLKL | - | 202 |
HLA-A*02:02 | GFKLKDCVMYA | - | 239 | - |
HLA-A*02:02 | TSLSGFKLKDCVMYA | TSLKLKDCVMYA | - | 244 |
HLA-A*02:02 | WLDMVDTSLS | - | 441 | - |
HLA-A*02:02 | LDMVDTSLSGFKL | LDMVDTSLKL | 9971 | 106 |
HLA-A*02:02 | SLSGFKLKDCV | SLKLKDCV | 408 | 10216 |
HLA-A*02:02 | LSGFKLKDCVMYA | LKLKDCVMYA | 305 | 28 |
HLA-A*02:02 | WLDMVDTSLSGFKL | WLDMVDTSLKL | 788 | 116 |
HLA-A*02:02 | SLSGFKLKDCVMYA | SLKLKDCVMYA | 55 | 171 |
Reference CVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHF
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated CVNCLDDRCILHCANFNVLFSTVFPFTSFGPLVRKIFVDGVPFVVSTGYHF
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-A*02:02 | TVFPPTSFGPLV | TVFPFTSFGPLV | 789 | 137 |
HLA-A*02:02 | VLFSTVFPP | VLFSTVFPF | 269 | 106 |